Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04508751 · ClinicalTrials.gov registry record · Phase 1
PED NEONAT 20-000599 Fetal Body Composition
A Phase 1 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT04508751 is a Phase 1 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 23 participants.
The verdict
NCT04508751, a Phase 1 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
Obesity is an ongoing public health problem that is difficult to treat. There is evidence that obesity has fetal origins. Body composition, including visceral, subcutaneous, brown, and hepatic fat have been found to be important predictors in obesity and metabolic syndrome. Magnetic resonance imaging (MRI) can quantify body composition that does not require radiation but is motion limited. The investigators have developed a motion-compensated MRI sequence, also known as "free breathing" MRI. In this study, the investigators plan to obtain free-breathing MRIs of pregnant women in the third trimester of pregnancy. MRIs will be obtained from healthy mothers, mothers with growth-restricted fetuses, and mothers with gestational diabetes. The different types of adipose tissue will be measured and compared between groups and correlated to birth growth parameters. The goal is this study is to assess if motion-compensated MRI can help predict early growth patterns in infancy.
Interventions
- OTHER 3T "Free-Breathing" Fetal Magnetic Resonance Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2020-08-17 |
| Est. Completion | 2022-05-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04508751
The ClinicalTrials.gov registry entry for NCT04508751 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 3T "Free-Breathing" Fetal Magnetic Resonance Imaging is the first listed.
NCT04508751 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04508751 about?
NCT04508751 is a clinical study titled "PED NEONAT 20-000599 Fetal Body Composition". Obesity is an ongoing public health problem that is difficult to treat. There is evidence that obesity has fetal origins. Body composition, including visceral, subcutaneous, brown, and hepatic fat have been found to be important predictors in obesity and metabolic syndrome. Magnetic resonance imagin...
What is the current status of trial NCT04508751?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2020-08-17. Estimated completion is 2022-05-18.
What interventions are being tested in trial NCT04508751?
The interventions under investigation include: 3T "Free-Breathing" Fetal Magnetic Resonance Imaging (OTHER).
Who is sponsoring clinical trial NCT04508751?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.